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The major leukocyte population in the decidua during the ﬁrst trimester of pregnancy
consists of NK cells that express receptors capable of recognizing MHC class I molecules
expressed by placental trophoblast. These include members of the killer immunoglobulin-
like receptor (KIR) family, the two-domain KIR (KIR2D), which recognize HLA-C. Interac-
tions between decidual NK (dNK) cell KIR2D and placental HLA-C contribute to the success
of pregnancy and dNK cells express KIR2D at higher frequency than peripheral NK (pNK)
cells. Thus, they are biased toward recognizing HLA-C. In order to investigate when this
unusual KIR repertoire appears, we compared the phenotype of NK cells isolated from
non-pregnant (endometrium) and pregnant (decidua) human uterine mucosa. Endo-
metrial NK (eNK) cells did not express KIR2D at a higher level than matched pNK cells, so
the bias toward HLA-C recognition occurs as a response to pregnancy. Furthermore,
HLA-C expression was upregulated on uterine stromal cells as the mucosa transformed
from endometrium to decidua at the onset of pregnancy. As uterine NK (uNK) cells can
mature from NK precursors and acquire KIR expression in utero, the pregnancy-speciﬁc
bias of uNK cells toward HLA-C recognition could arise as developing uNK cells interact
with uterine stromal cells, which express higher levels of HLA-C during pregnancy.
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Introduction
NK cells are the major leukocyte population in the decidua during
the ﬁrst few months of pregnancy and are also present in the non-
pregnant endometrium [1–3]. NK cells are sparse in the
proliferative phase of the menstrual cycle, but following ovula-
tion, in the secretory phase, they proliferate, enlarge and become
granulated. If fertilization occurs, the NK cells continue to
proliferate in the decidua during the ﬁrst trimester of pregnancy.
If fertilization does not occur, they die 24–48h before menstrua-
tion and are shed with the menses. Uterine NK (uNK) cells have
cytolytic granules, but unlike their peripheral counterparts are
poorly cytotoxic [4–6]. Instead, their function is likely to be to
sense and respond to trophoblast, leading to regulated tropho-
blast invasion and spiral artery remodeling [7, 8]. In order to do
this, mechanisms must exist for uNK-cell recognition of tropho-
blast and uNK, like peripheral blood NK (pNK) cells, express a
variety of receptors, including those speciﬁc for MHC class I
molecules. These are of particular interest as invasive extravillous
trophoblast (EVT) has a unique complement of ligands for NK
receptors: the non-classical class I molecules HLA-E and -G and
the classical HLA-C [9]. CD94/NKG2A binds to HLA-E and is
expressed by the majority of decidual NK (dNK) cells [10, 11].
LILRB1 is expressed by approximately 20% of dNK cells and is
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particularly high afﬁnity for HLA-G [12].
HLA-C is the only polymorphic MHC molecule expressed by
trophoblast and is the major ligand for members of the killer
immunoglobulin-like receptor (KIR) family. KIRs also show
considerable polymorphism in both number of KIR genes and
allelic variation at individual KIR loci. KIRs speciﬁc for HLA-C can
encode inhibitory (KIR2DL) or activating (KIR2DS) receptors that
can discriminate between two groups of HLA-C allotypes (C1 and
C2) based on a dimorphism at position 80. In general, KIR2DL1/S1
bind to C2 allotypes and KIR2DL2/3 bind to C1 allotypes, although
KIR2DL2 also binds to C2 allotypes with low affﬁnity [13–17].
Genetic and in vitro data suggest that the combination of
maternal KIR and fetal HLA-C genotypes affects the depth of
trophoblast invasion [7, 18–20]. dNK cells express KIR2D speciﬁc
for HLA-C at a higher frequency and level than pNK cells, meaning
that they are especially equipped to recognize HLA-C [21, 22]. This
bias is lost over the course of gestation so that by the second
trimester the dNK-cell KIR repertoire is similar to that of pNK.
Recently, we have shown that immature (stage 3) NK cells,
capable of differentiating to mature NK cells in vitro, are present in
the uterine mucosa, both before and during pregnancy [23]. Since
immature NK cells do not express any receptors for MHC class I, it
is likely that uNK acquire their KIR repertoire within the uterine
microenvironment. Thus, factors present in the endometrium,
decidua, or both, may affect uNK-cell receptor acquisition.
If factors common to the endometrium and decidua (that is, to
the uterine microenvironment in general) mediate the acquisition
of the uNK-cell KIR-repertoire, we would expect both endometrial
NK (eNK) and dNK cells to display a similar bias toward HLA-C
recognition. If, on the other hand, the bias arises in response to
trophoblast- or pregnancy-speciﬁc factors, it would only be
present in dNK, and not eNK cells. Here, we report that the KIR
repertoire of eNK cells and dNK cells differs, with the bias toward
HLA-C recognition only arising during pregnancy. Moreover,
HLA-C expression by uterine stromal cells increases as they
decidualize at the onset of pregnancy, suggesting that the
acquisition of the KIR bias toward HLA-C recognition may be
mediated by stromal cells in utero.
Results
Phenotype of eNK cells
The phenotype of dNK cells is already well established (Table 1),
but there have been few similar studies using FACS on CD56
1
eNK. Therefore, we ﬁrst compared the phenotype of freshly
isolated CD56
1 eNK with that of dNK (Fig. 1). All NK cells, both
in the endometrium and in the decidua, expressed the activating
receptors NKG2D and NKp46. By contrast, NKp44 was expressed
by neither eNK nor dNK. CD161 (NKRP1) was expressed by all
eNK but at a reduced level by dNK, while CD69, which is a
marker of activation, was expressed at a lower level by eNK than
dNK. For both of these antigens, there was no overlap between
the endometrial and decidual sets of MFIs, but using non-
parametric statistical testing it is not possible to say that the
differences observed were statistically signiﬁcant. All uNK cells
expressed the IL-2 receptor beta chain CD122, whereas none
expressed the IL-7 receptor alpha chain CD127. Thus, with the
exceptions of CD161 and CD69, which may differ in their level of
expression between eNK and dNK, overall the uNK-cell pheno-
type was very similar in the non-pregnant and pregnant uterus.
The inhibitory NK receptors that will recognize the tropho-
blast MHC molecules HLA-G and HLA-E are LILRB1 and CD94/
NKG2A respectively, and these receptors were expressed at
similar frequencies by eNK and dNK (Fig. 1). There is still no
consensus about whether KIR2DL4 recognizes HLA-G and which
NK cells express this KIR [24]. Using a variety of monoclonal
antibodies, we have never been able to detect KIR2DL4
Table 1. Phenotype of eNK as deﬁned by previous studies
a)
pNK pNK eNK dNK References
CD56 Dim Bright Superbright Superbright [2, 38]
CD16 1 – – – [2, 36, 38]
2B4 11 ND 1 [26, 45, 56]
CD9  11[38, 44]
CD94 /1 ()/1 ()/1 ()/1 [11, 35, 37]
CD69  ND 1 [44]
CD117  Dim ND Dim [60]
KIR /1  /1 /1 [21, 22, 35, 37]
NKG2D 11 1 1 [36, 43, 59]
NKp30   Disputed [7, 26, 36, 43, 45]
NKp44   Disputed [7, 26, 36, 43, 45]
NKp46 11 1 1 [7, 26, 36, 43, 45]
Perforin 1 Dim 11[5, 44, 61]
Granzyme 1 Dim 11[5, 44, 61]
a)  no expression of marker, 1 all cells positive, /1 some cells negative, some positive, ()/1 some cells negative but most positive,
ND; not done.
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(our unpublished observations). We compared the frequency of
LILRB1 and NKG2A expression on eNK with that of pNK taken
from the same woman at the same time. NKG2A was expressed at
a signiﬁcantly higher frequency by eNK compared with pNK
(n59; Fig. 2B) whereas LILRB1 was expressed at signiﬁcantly
lower frequency by eNK compared to pNK (n510; Fig. 2A).
The uNK cell bias toward recognizing HLA-C is not
present before pregnancy
We have recently reported the presence of immature NK cells,
which do not express any receptors for MHC class I, in the uterine
mucosa. These cells are able to progress to a mature NK
phenotype in vitro, acquiring CD94 and losing CD117 expression
[23]. To see whether immature NK cells in the uterus can also
acquire KIR expression, we cultured them for 2wk with
recombinant human IL-15 and examined their expression of
CD117, CD94 and KIR2DL1/S1 by FACS. Those cells that
acquired CD94 also expressed some KIR (5–34%) whereas those
that did not acquire CD94 remained KIR
 (Fig. 3A–C). Therefore,
the hormonally driven microenvironment in the uterine mucosa,
where these immature NK cells acquire KIRs, is likely to inﬂuence
the uNK cell KIR repertoire.
To determine whether the KIR repertoire was altered by
pregnancy, we next compared the expression of KIRs by uNK
from either endometrium or decidua (Fig. 1) with that of
matched pNK. Taking either endometrial (n518) or decidual
(n513) isolates and peripheral blood leukocytes, CD56
1 cells
were examined for expression of KIR3DL1, KIR2DL1/S1 and
KIR2DL2/L3/S2. The analysis of data as matched pairs, which
has not been done in previous studies, takes into account the
marked differences in KIR expression between individuals [25].
Similar to our earlier ﬁndings, the frequency of NK cells positive
for either KIR2DL1/S1 (speciﬁc for HLA-C2) or KIR2DL2/L3/S2
(KIR2DL2 and -2DL3 recognize HLA-C1) was signiﬁcantly higher
in the decidua than matched blood (Fig. 3K and L). In contrast,
there was no signiﬁcant difference in frequency of KIR3DL1
1 NK
cells (speciﬁc for HLA-Bw4; HLA-B is not expressed by tropho-
blast cells) (Fig. 3J). Similar results were observed in both KIR AA
donors, and individuals who expressed activating KIRs. This
provides additional conﬁrmation that dNK are more equipped to
recognize HLA-C molecules than their peripheral counterparts
[21, 22].
The high frequency of KIR2D expression on uNK could either
be due to a pregnancy-speciﬁc factor or occur as a result of factors
common to the mucosal microenvironment in utero both before
and during pregnancy. Therefore, we examined the KIR reper-
toire of eNK cells from either the proliferative (n57) or the
secretory (n511) phase of the menstrual cycle, compared with
matched pNK. As expected, eNK expressed KIR3DL1 with a
frequency that was not signiﬁcantly different from that of pNK
(Fig. 3D and G). Unlike dNK, though, there was no signiﬁcant
difference between expression of KIR2D in blood and eNK cells,
at any phase of the menstrual cycle (Fig. 3E–F, H–I). We conclude
that the bias toward KIR recognition of HLA-C is only a feature of
uNK cells in pregnancy. Consistent with this, the frequency of
Figure 1. Phenotype of eNK and dNK cells. Freshly isolated preparations of endometrial and decidual leukocytes were gated on scatter and CD56
1
cells. The gated cells were examined for expression of the markers indicated. The test stains are indicated by the bold lines; isotype control
staining by dotted lines. For decidua, each panel represents at least three independent samples. For endometrium, the number of samples stained
and their clinical details are given in Table 2. For CD161 and CD69, the mean MFI of all samples examined are indicated in the upper right corner.
For other markers, MFI did not differ.
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this was only signiﬁcant for KIR2DL2/L3/S2.
The KIR repertoire of pNK and uNK cells are different
before pregnancy
An additional feature observed was that, compared with pNK, there
were very few uNK cells expressing KIR2DL1/S1 alone (Fig. 4A
gate Y). This means that most KIR2DL1/S1
1 NK cells also expressed
KIR2DL2/L3/S2 (Fig. 4A gate X). The number of these KIR2D
double-positive cells (KIR2DL1/S1
1KIR2DL2/L3/S2
1;F i g .4 A
gate X) as a proportion of the total number of KIR2DL1/S1
1 cells
(Fig. 4A gate Z) was consistently higher in uNK than in matched
pNK, both in endometrium and decidua, suggesting that it is due to
factors independent of pregnancy (Fig. 4B and C).
Figure 2. eNK cells have a lower frequency of LILRB1 but a higher
frequency of NKG2A expression than their peripheral counterparts.
The frequency of receptor expression in pNK is shown on the left of
each graph; frequency in eNK cells is shown on the right. Matched
pairs are joined by a line. Frequency of (A) LILRB1 and (B) NKG2A
expression are shown. p o 0.05, p o 0.01, Wilcoxon signed rank test. All
data points obtained are represented on the plots.
Figure 3. KIR2D are more frequently expressed in dNK cells than pNK cells, but there is no difference between pNK cells and eNK cells. (A) Immature
(stage 3) NK cells were isolated from the decidua and cultured for 2wk in 1nM IL-15. Expression of CD117 and CD94 at the end of culture is shown. (B)
KIR expression by those immature NK cells that had not differentiated by the end of the culture period. (C) KIR expression by the in vitro-generated
mature NK cells. (A–C) are representative of three independent experiments. (D–L) KIR expression in freshly isolated CD56
1 uNK cells compared with
that of freshly isolated matched CD56
1 pNK cells: frequency of KIR expression in pNK cells is shown on the left of each graph, frequency in uNK cells
is shown on the right, matched pairs are joined by a line. Expression of (D, G, J) KIR3DL1, (E, H, K) KIR2DL1/S1 and (F, I, L) KIR2DL2/L3/S2 are shown in
proliferative endometrium (D–F), secretory endometrium (G–I) and decidua (J–L) respectively. p o 0.001, Wilcoxon signed rank test.
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repertoire
Following implantation, HLA-C
1 EVT invade into the decidua,
where they intermingle with uNK cells. It is possible that the skew
toward KIR2D expression could arise as a response to the higher
levels of HLA-C expression on EVT, compared with other cells in
the mucosa [20]. In this case, we might expect KIR expression on
uNK to be skewed not just toward recognition of HLA-C in
general, but toward recognition of the speciﬁc HLA-C (group 1 or
2) expressed by the trophoblast in each pregnancy. To examine
this possibility, we extracted genomic DNA from placental villi
and typed the samples for HLA-C1/C2 in an attempt to correlate
fetal HLA-C genotype with the expression of cognate KIRs on
maternal uNK cells. The presence of trophoblast HLA-C2 or -C1
did not increase the proportion of dNK-expressing KIR2DL1/S1 or
KIR2DL2/L3/S2, respectively (Supporting Information Fig. 1A
and B). As well as recognizing HLA-C1, KIR2DL2 also binds to
HLA-C2 alleles with low afﬁnity, and this could have confounded
the analysis [16, 17], but even when KIR2DL2
1 individuals were
excluded from the analysis, no correlation between placental
HLA-C and maternal expression of KIRs was found. Thus, the
pregnancy-speciﬁc bias of uNK toward recognition of HLA-C does
not appear to be a response to HLA-C expression by trophoblast.
Soluble factors present in the pregnant uterus cannot
recapitulate the dNK-cell bias toward HLA-C recognition
A soluble factor produced by trophoblast cells might account for
the dNK-cell bias toward HLA-C recognition. However, there was
no difference in KIR expression by eNK cultured either in the
presence or absence of trophoblast-conditioned medium
(Supporting Information Fig. 2A–C). Another possibility is that
IL-15, which is expressed in the uterine mucosa in a progester-
one-dependent manner and is known to affect KIR expression by
NK cells, could account for the unique dNK-cell KIR repertoire
[26–29]. To investigate this, we cultured eNK in either the
presence or absence of 2.5ng/mL IL-15 and this did increase
KIR2D expression, compared with culture without cytokines.
However, IL-15 also promoted the maintenance of KIR3DL1
expression and thus is unlikely to account for the dNK-cell bias
toward HLA-C recognition (Supporting Information Fig. 2D–F).
HLA-C levels are increased on decidual compared with
endometrial stromal cells
The MHC class I molecules expressed by bone marrow stromal
cells are important for the acquisition of the Ly49 repertoire by
developing mouse NK cells [30]. The same may to be true of KIR in
humans and certainly in vitro NK differentiation does require
stromal feeder cells for robust KIR acquisition [31]. Therefore, a
change in HLA-C expression by uterine stromal cells could account
for the pregnancy-speciﬁc skew toward HLA-C recognition in uNK.
To test this hypothesis, we stained uterine stromal cells (identiﬁed
by scatter and as CD10
1CD45
 cells: Fig. 5A–F) with the
monoclonal antibody DT9, which is speciﬁc for HLA-C on primary
cells [32, 33]. DT9 does not bind to beads bearing any common
alleles of HLA-A or -B, except for HLA-A80 and -B73 [32, 33], but
can bind to cell lines that overexpress HLA-E [32–34]. However,
we observed no staining of uterine stromal cells with the
HLA-E-speciﬁc monoclonal antibody 3D12 by ﬂow cytometry
(Fig. 5G). Thus, DT9 staining is representative of HLA-C
Figure 4. NK cells expressing KIR2DL1/S1 but not KIR2DL2/L3/S3 are
rarer in the uterus than matched blood. (A) Preparations of leukocytes
freshly isolated from endometrium, decidua or peripheral blood were
gated on CD56
1 and examined for KIR2DL1/S1 and KIR2DL2/L3/S2
expression. Gate Z contains all KIR2DL1/S1 positive cells; gate X KIR2D
double-positive cells (KIR2DL1/S1
1KIR2DL2/L3/S3
1); gate Y contains
KIR2DL1/S1 single-positive cells. The proportion of KIR2DL1/S1
1 NK
cells that are KIR2D double positive is quantitated by dividing the
number of cells in gate X by gate Z. Comparisons between (B) blood and
endometrium and (C) blood and decidua are shown. p o 0.01,
p o 0.001, Wilcoxon signed rank test. (B, C) All data points obtained
are represented on the plots.
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stromal cells in the endometrium (Fig. 5H and I) but levels of
expression were signiﬁcantly higher on decidual cells (Fig. 5J and
K; p o 0.01), indicating that HLA-C levels increase as stromal cells
decidualize.
Discussion
Humans and other menstruating primates are unique among
mammals in that their uterine mucosa commences its transforma-
tion from endometrium to decidua before implantation occurs, in
the secretory phase of every menstrual cycle. NK cells are a feature
of decidua and, during this phase of the cycle, eNK proliferate
vigorously under the inﬂuence of progesterone. No side-by-side
comparison of receptor expression by eNK and dNK has previously
been undertaken; here, we characterize these eNK cells in detail.
Similar to dNK and in agreement with previous reports
(Table 1), CD56
bright eNK are uniformly positive for NKG2D and
NKp46, uniformly negative for NKp44, mostly positive for NKG2A
and a substantial proportion express KIR [35–38]. Thus, using
these phenotypic markers, eNK are identical to dNK cells. We also
show that a fraction (mean 18.2%) of eNK express the inhibitory
receptor LILRB1, comparable to the 20% of LILRB1
1 dNK [12]. In
addition, eNK are uniformly positive for CD161, although stain-
ing for CD161 was stronger on eNK than on dNK. The ligand for
CD161, LLT1, is expressed by trophoblast [39, 40], suggesting
that CD161 may be downregulated by dNK in the presence of its
ligand. The unique NK cells found in the pregnant mouse uterus
are also negative for CD161 (NK1.1) [41]. Consistent with a
comparison of eNK and dNK-cell transcriptomes, the activation
marker CD69 is more highly expressed by dNK than eNK, indi-
cating that uNK cells have become activated during pregnancy
[42]. We found that NKp44 was not expressed on dNK, in
agreement with one previous report [43] but in conﬂict with
others [7, 44, 45]. In at least one of the latter studies, dNK were
cultured before analysis with IL-2, which is known to induce
NKp44 expression [46]. Thus, eNK and dNK are phenotypically
very similar, so that many of the unique phenotypic features of
uNK are present before pregnancy.
Figure 5. HLA-C is more highly expressed by decidual than endometrial stromal cells. (A) Cultured decidual stromal cells were gated by scatter
characteristics and (B) examined for their expression of CD10 and CD45. Total fresh decidual and endometrial cell preparations were gated by
(C) scatter characteristics and on (D) CD10
1CD45
 cells. These cells were negative for (E) the endothelial cell marker CD31, (F) the epithelial cell
marker cytokeratin 7, and (G) HLA-E was undetectable on the cell surface. Geometric mean ﬂuorescence intensity when staining with the
HLA-C-speciﬁc antibody DT9 on stroma from (H) proliferative endometrium, (I) secretory endometrium and (J) decidua is shown. Antibody staining
is indicated by the bold lines; isotype control staining is indicated by dotted lines. (K) The scatter plot shows all values obtained (n52 proliferative
samples and n54 each of secretory and decidual). p o 0.01, comparing endometrial (proliferative and secretory together) and decidual data
points, Mann–Whitney U test.
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is CD127
1 and IL-7-dependent, while the other is CD122
1 and
IL-15-dependent [47]. It is therefore interesting that uNK express
CD122 (IL-2Rb, a component of the IL-15 receptor) but not
CD127 (IL-7Ra), in keeping with the known hormonal regulation
of IL-15 in the uterine mucosa [26, 27]. Most evidence thus
points to uNK belonging to the IL-15-dependent lineage. That
uNK are able to develop in response to IL-15 is evident from our
report that IL-15 is sufﬁcient to induce maturation of the imma-
ture NK cells present in endometrium and decidua [23]. Here, we
demonstrate that IL-15 also induces KIR expression on these NK
precursors as they differentiate to mature NK cells in vitro. When
this occurs in vivo, the uterine microenvironment will affect uNK-
cell receptor repertoire acquisition. The unusual KIR repertoire in
dNK, which is skewed toward recognizing HLA-C, is not present
in eNK. Thus, uNK cells are only biased toward recognizing
HLA-C after pregnancy has begun. However, some subtle differ-
ences in the uNK-cell KIR repertoire are present even before
pregnancy: NK cells expressing only KIR2DL1/S1, and not also
expressing KIR2DL2/L3/S2, are very scarce in the uterus
compared with the periphery, and this is true of both eNK and
dNK. KIR2DL2/3 is expressed before KIR2DL1, so one possible
way to account for this observation is that KIR2D negative uNK
are not permitted to acquire KIR2DL1 until they have ﬁrst
acquired KIR2DL2/L3 [17, 48–50]. This explanation also reso-
nates with observations of KIR acquisition by donor NK cells in
hematopoietic stem cell transplant recipients over time [49, 50].
At early time points after transplantation, very few cells are
positive for only KIR2DL1/S1, so this abundance of KIR2D
double-positive NK cells may be a feature of NK cells that have
only recently matured and acquired KIR.
Trophoblast expresses high levels of HLA-C [20] and we
therefore considered that the pregnancy-speciﬁc bias toward
HLA-C recognition might be caused by the selective expansion of
those NK cells that could recognize trophoblast. We were unable
to correlate frequency of KIR expression with the presence of
cognate HLA-C on trophoblast, but the numbers in this study are
small and a trend may still emerge with larger numbers. Indeed,
expression of KIR2DL1/S1 by CD3
1 T cells in term decidua is
affected by fetal HLA-C2 expression [51]. Term and ﬁrst trimester
decidua differ in a number of important ways: in particular, the
dNK-cell skew toward HLA-C recognition is lost over the course of
pregnancy [22] and is entirely absent at term [51]. In this
context, whether T cells from ﬁrst trimester decidua have the
ability to recognize HLA-C by either TCR or KIRs is unknown. In
culture, we were unable to recapitulate the skew toward KIR2D
expression observed in dNK, either by treating eNK with soluble
factors produced by trophoblast, or with IL-15. Therefore, none
of these factors seem likely to be responsible for the dNK-cell bias
toward HLA-C recognition.
The explanation we favor to account for this bias is that,
during decidualization, stromal cells upregulate surface expres-
sion of HLA-C. Our results using the HLA-C-speciﬁc monoclonal
antibody DT9 conﬁrm the puzzling report that HLA-C, but not -A
or -B, transcripts are increased in secretory compared with
proliferative endometrium [52]. Uterine stromal cells express
progesterone receptors and undergo a number of changes in
response to progesterone [53, 54]. The observations reported
here, together with those previously published on HLA tran-
scription over the menstrual cycle [52], suggest that HLA-C
expression is likely to be progesterone-responsive in these cells.
The lack of HLA-A and -B-speciﬁc antibodies does make it difﬁcult
to deﬁnitively conﬁrm that the increase in uterine stromal HLA-C
expression during pregnancy does not also encompass HLA-A
and -B molecules. However, when cells from HLA-A2
1 indivi-
duals were examined with the HLA-A2-speciﬁc antibody BB7.2,
we observed no differences between endometrial and decidual
stroma (not shown). uNK are ﬁrmly associated with stromal cells
by a variety of integrin/matrix interactions and, by electron
microscopy, the two are in intimate contact in vivo [55, 56].
Furthermore, the effect of uterine stroma on developing NK cells
is likely not to be limited to cell–cell interactions: conditioned
medium from decidual stromal cells has been shown to induce a
uNK-cell-like phenotype in pNK, and this is TGFb-dependent
[57]. Therefore, there is the opportunity for extensive cross-talk
between uNK and uterine stromal cells that can affect uNK-cell
development and repertoire acquisition.
In summary, we ﬁnd that, although both eNK and dNK express
KIRs, it is only dNK that are consistently biased toward recognition
of HLA-C. Expression of HLA-C on uterine stromal cells
increases during decidualization at the beginning of pregnancy.
This could explain the pregnancy-speciﬁc bias of uNK toward
HLA-C recognition, which only arises when immature NK
cells in the uterus acquire their KIR repertoire in the presence of
high levels of stromal HLA-C. Thus, as well as the profound effects
decidualization has on stromal, glandular and vascular elements of
the mucosa, it also affects uNK-cell activation and KIR repertoire.
Materials and methods
Primary tissue
Protocols using human tissue were approved by the Cambridge
Local Research Ethics committee (study numbers 04/Q0108/23
and 08/H0305/40). Totally, 30 endometrial samples were taken
by Pipelle biopsy from normally cycling women attending for tubal
ligation. Samples from women who were bleeding at the time of
surgery were assigned as menstrual. Other samples were designated
p r o l i f e r a t i v eo rs e c r e t o r yo nt h eb a s i so fc y c l ed a yn u m b e ra n d
serum progesterone (Table 2). Totally, 27 decidual samples were
taken from women attending for elective termination of pregnancy
between 8 and 11wk after their last menstrual period. Matched
venous blood was obtained from all patients at the time of surgery.
Lymphocytes were extracted from peripheral blood by layer-
ing onto Lymphoprep (Axis-Shield) and taking the interface. Cells
were extracted from uterine samples as described [58]. Brieﬂy,
pieces of uterine tissue were washed in RPMI 1640 medium
(Gibco), minced and digested with collagenase V (Sigma)
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12h, room temperature). The suspension was passed through a
series of cell strainers to 40mm, and layered onto Lymphoprep to
enrich for leukocytes. The interface was taken, washed in PBS and
stained immediately, or cultured for up to seven days in RPMI
1640 medium, plus antibiotics, 10% FCS and any other indicated
additions. All uterine samples were double stained for CD56 and
CD9 (Fig. 1) and those with any CD56
1CD9
 cells present
discarded as this indicates contamination by maternal blood
leukocytes [44]. Decidual stromal cells were separated from the
leukocytes and cultured as described [58]. Immature (stage 3)
dNK cells were extracted and cultured as described [23].
Flow cytometry
Cells were suspended in 0.2mg/mL human g globulins (Sigma)
(15min, 41C) to block non-speciﬁc binding before incubation with
ﬂuorochrome-conjugated antibody (30min, 41C). Directly conju-
gated antibodies were: CD56, KIR2DL1/S1 clone EB6, LILRB1
clone HPE-F1 (Beckman Coulter); CD9, CD94 (clone 131412),
KIR2DL2/L3/S2 (BD); CD10, CD31, CD45, CD56, CD69, CD117
(clone 104D2), CD122, KIR3DL1 clone DX9, NKG2D, NKp44
(Biolegend); cytokeratin 7 (Dako), which was detected intracellu-
larly using FIX & PERM (ADG); CD127 (eBioscience); NKp46
(R&D). NKG2A (clone Z199, Beckman Coulter), CD161 (BD),
HLA-C (DT9, a kind gift of Veronique Braud) and HLA-E (clone
3D12, eBioscience) expression was examined by indirect staining.
Cells were blocked in human g globulins and incubated with
primary antibody (30min, 41C), then washed and incubated with
PE anti-mouse (Sigma) (30min, 41C). Following a further wash,
cells were blocked in 0.1mg/mL mouse g globulins (Sigma)
(15min, 41C) and stained with directly conjugated antibody as
above. Data were collected on a BD FACScalibur, with at least
10000 events collected through the gate of interest.
Genotyping of KIR and HLA-C
KIR and HLA-C were typed from genomic DNA as described
[18, 19]. Brieﬂy, the individual genes were genotyped by PCR for
their presence or absence with sequence-speciﬁc primers using
two pairs of primers per gene or allele. KIR genes typed were
3DL1, 3DS1, 2DL1, 2DL2, 2DL3, 2DL5, 2DS1, 2DS2, 2DS3, 2DS4,
Table 2. Clinical details of non-pregnant donors
Patient Cycle day Cycle length Serum progesterone (ng/mL) Phase assigned Antigens examined
01 2 24 0.69 Menstrual CD9, KIR
02 4 24 1.38 Menstrual CD9, KIR
03 2 28 Not tested Menstrual CD9, LILRB1
04 1 28 Not tested Menstrual CD9. KIR
05 13 28 0.75 Proliferative CD9, KIR
06 4 25 1.29 Proliferative CD9, KIR, NKG2A, LILRB1
07 17 28 1.82 Proliferative CD9, KIR, LILRB1
08 6 28 Not tested Proliferative CD9, KIR
09 8 28 1.06 Proliferative CD9, KIR, LILRB1
10 9 28 0.79 Proliferative CD9, KIR
11 8 28 0.85 Proliferative CD9, KIR
12 7 28 0.62 Proliferative CD9, CD69, CD161
13 27 28 7.52 Secretory CD9, KIR
14 24 28 6.73 Secretory CD9, KIR, NKG2A, LILRB1
15 26 28 2.45 Secretory CD9, KIR, NKG2A, LILRB1
16 19 28 6.82 Secretory CD9, KIR, NKG2A, LILRB1
17 20 28 11.73 Secretory CD9, KIR, NKG2A, LILRB1
18 25 32 18.81 Secretory CD9, KIR
19 24 32 11.35 Secretory CD9, KIR, LILRB1
20 17 28 13.84 Secretory CD9, KIR
21 19 28 3.9 Secretory CD9, KIR
22 19 28 7 Secretory CD9, KIR, NKG2A, LILRB1
23 18 28 23.69 Secretory CD9, NKG2A
24 18 28 14.08 Secretory CD9, NKG2A
25 14 28 28.1 Secretory CD9, NKG2A, LILRB1
26 19 25 4.43 Secretory CD9, KIR
27 21 28 Not tested Secretory CD9, CD127
28 21 28 1.63 Secretory CD9, CD122
29 27 28 2.95 Secretory CD9, NKG2D
30 29 31 6.98 Secretory CD9, CD69, CD161, NKp44, NKp46
Eur. J. Immunol. 2011. 41: 3017–3027 Victoria Male et al. 3024
& 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu2DS5 and 2DP1. Typing for HLA-C was performed using a similar
approach, which allowed all known HLA-C group C1 alleles to be
distinguished from C2 alleles.
Statistical analysis
The frequencies of KIR expression in matched blood and uterine
NK cells were compared using the Wilcoxon signed rank test. The
Mann–Whitney U test was used to make comparisons between
non-matched data sets. The results with po0.05 were considered
signiﬁcant.
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